Search

Displaying results 5051 - 5060 of 6076 in total
  1. Drug

    TPMPA

    go.drugbank.com/drugs/DB16754
    Experimental

    [A245308,A245313] TPMPA is used as a pharmacological probe for the investigation of GABA<sub>C</sub> receptor function.[A245313]

  2. Drug

    Brofaromine

    go.drugbank.com/drugs/DB13876
    Experimental

    Categories: Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates
  3. Drug

    Endostatin

    go.drugbank.com/drugs/DB06423
    Investigational

  4. Drug

    AS-602868

    go.drugbank.com/drugs/DB33577
    Experimental

    Categories: Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates
  5. Drug

    Metoprolol

    go.drugbank.com/drugs/DB00264
    ApprovedInvestigational

    Metoprolol is a selective beta-1 blocker commonly employed as the succinate and tartrate derivatives depending if the formulation is designed to be of immediate release or extended release. The possibility of the generation of these form...

    Categories: Antihypertensive Agents Indicated for Hypertension
  6. Drug

    Mesulfen

    go.drugbank.com/drugs/DB13356
    Experimental

    Categories: Anti-Acne Preparations for Topical Use
  7. Drug

    Aluminium glycinate

    go.drugbank.com/drugs/DB13626
    Investigational

    Categories: Drugs for Acid Related Disorders
  8. Drug

    Camylofin

    go.drugbank.com/drugs/DB13738
    Experimental

    Categories: Drugs for Functional Gastrointestinal Disorders
  9. Drug

    Eflapegrastim

    go.drugbank.com/drugs/DB15001
    ApprovedInvestigational

    The primary factor associated with FN risk is the chemotherapy regimen being administered - regimens are classified as either high-, intermediate-, or low-risk for FN, and relevant guidelines recommend

  10. Drug

    Polyinosinic-polycytidylic acid

    go.drugbank.com/drugs/DB16467
    Investigational

    Categories: Experimental Unapproved Treatments for COVID-19